Cargando…
A trial of the immunogenicity of inactivated hepatitis A vaccine administered with immune serum globulin
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
1992
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131640/ http://dx.doi.org/10.1016/0264-410X(92)90274-N |
| _version_ | 1783517284475600896 |
|---|---|
| author | Green, M. Cohen, D. Lerman, Y. Sjogren, M. Binn, L. Tsur, S. Slepon, R. Robin, G. Hoke, C. Danon, Y. |
| author_facet | Green, M. Cohen, D. Lerman, Y. Sjogren, M. Binn, L. Tsur, S. Slepon, R. Robin, G. Hoke, C. Danon, Y. |
| author_sort | Green, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7131640 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1992 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71316402020-04-08 A trial of the immunogenicity of inactivated hepatitis A vaccine administered with immune serum globulin Green, M. Cohen, D. Lerman, Y. Sjogren, M. Binn, L. Tsur, S. Slepon, R. Robin, G. Hoke, C. Danon, Y. Vaccine Article Published by Elsevier Ltd. 1992 2002-11-13 /pmc/articles/PMC7131640/ http://dx.doi.org/10.1016/0264-410X(92)90274-N Text en Copyright © 1992 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Green, M. Cohen, D. Lerman, Y. Sjogren, M. Binn, L. Tsur, S. Slepon, R. Robin, G. Hoke, C. Danon, Y. A trial of the immunogenicity of inactivated hepatitis A vaccine administered with immune serum globulin |
| title | A trial of the immunogenicity of inactivated hepatitis A vaccine administered with immune serum globulin |
| title_full | A trial of the immunogenicity of inactivated hepatitis A vaccine administered with immune serum globulin |
| title_fullStr | A trial of the immunogenicity of inactivated hepatitis A vaccine administered with immune serum globulin |
| title_full_unstemmed | A trial of the immunogenicity of inactivated hepatitis A vaccine administered with immune serum globulin |
| title_short | A trial of the immunogenicity of inactivated hepatitis A vaccine administered with immune serum globulin |
| title_sort | trial of the immunogenicity of inactivated hepatitis a vaccine administered with immune serum globulin |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131640/ http://dx.doi.org/10.1016/0264-410X(92)90274-N |
| work_keys_str_mv | AT greenm atrialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT cohend atrialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT lermany atrialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT sjogrenm atrialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT binnl atrialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT tsurs atrialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT sleponr atrialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT robing atrialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT hokec atrialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT danony atrialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT greenm trialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT cohend trialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT lermany trialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT sjogrenm trialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT binnl trialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT tsurs trialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT sleponr trialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT robing trialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT hokec trialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin AT danony trialoftheimmunogenicityofinactivatedhepatitisavaccineadministeredwithimmuneserumglobulin |